GiveBetter x Denver

Tepeyac Community Health Center

Bilingual integrated primary care, behavioral health, dental care and pharmacy

Research time: ~2 min on GPT-6.1 Sol
  • Modeling — estimated costs, QALYs and uncertainty.
  • Source audit — checked claims, assumptions and calculations.

Updated: 2026-10-06

Donate

Summary

What do they do? Tepeyac provides bilingual primary care, mental health support, dentistry and pharmacy services in Denver. Patients can receive short-term therapy, preventive and chronic-disease care in one clinic. It accepts insurance and offers sliding fees without refusing care solely for inability to pay.

Why we’re interested in this organization:

  • Matched2024 unique patient count and full original annual expense.

  • Integrated bilingual screening and6–12therapy sessions provide a concrete access mechanism.

  • Clinical patients and household resources remain separate, with active safety-net alternatives.

Our main reservations:

  • Unique patients do not identify completed depression treatment.

  • The trial utility reference comes from UK primary care, not local controlled outcomes.

  • Full clinic cost covers important primary, dental and pharmacy effects not quantified here.

What do you get for your dollar? $5.3M per DALY in Denver. DALY is our one-year comparison unit. QALY-based health gains and income-welfare equivalents retain their original assumptions; they are not measured clinical DALYs. Matched FY2024 full annual recipient cost against partial integrated depression-care mechanism; other primary/dental/pharmacy benefits unknown, not portfolio or marginal-gift EV..

2024annual7,901unique patients/35,438visits;5427behavioral/6248dental/18179primary visits not summed as people.

1. What do they do?

Tepeyac integrates bilingual primary care, behavioral health, dental care and pharmacy. Current behavioral health provides6–12sessions and case management plus referral to longer-term care. In2024 it served7,901unique patients across73zipcodes with35,438visits; service-line visits are not separate unique people.

2. Monitoring and information sharing

Request unique behavioral patients, diagnoses and completed dose; clinical utility against active alternatives; patient after-tax resources, fees and access costs; actual residence and unrestricted marginal capacity. Keep primary, dental and pharmacy channels separate from overlapping behavioral patients.

3. Qualitative assessment

The2024annual reports62%uninsured,22%public-insured and16%private-insured patients. Sliding fees and insurance enrollment can improve access but neither retail care value nor coverage approval is automatically net income. CADET randomized581 adults in UK primary care and found 0.02 incremental annual QALYs versus usual care, CI−.02,.06; Tepeyac's bilingual integrated model differs and recipient outcomes are unmeasured.

4. What do you get for your dollar?

FYDec2024 full cost $18,893,488 includes $133,641 netted event expense. The7,901unique patient envelope is observed; .15depression-compatible share, .7transfer/delivery and .3incremental enhanced-care share are judgments. q=.02 uses the trial's average annual incremental utility; response1 avoids a second responder factor. The .15eligible envelope1185clients times .7delivery830roughly fits5427behavioral visits at6–12sessions but is not an observed completion count. Clinical health retains all patients; .85household grouping applies only to resources. Judged adult/caregiver $300net work resources require eligible completed successful additional care and biological response, after taxes, benefit withdrawal and work costs; no child wages. Positive gains receive .5overlap discount; all households retain $5access/time loss and all patients .0001process harm. Actual avoided copays are centralzero judgments, with payer-incidence sensitivity rather than retail medical charity income. Denver share .95isjudged;73zipcodes are not a residence audit. Whole clinic costs versus partial BHbenefits do not estimate portfolio EV. Three-year mean and functional-only expense sensitivities quantify cost-boundary and expansion-scale uncertainty.

Model, assumptions and sensitivity

Full calendar2024 IRS recipient functional plus netted direct event expenses; new clinic scale and capital/recognized resource boundaries uncertain. Partial integrated BHbenefits only.

Judged .95share of unique patients resident in ten-county Denver CBSA19740;73zipcodes and MetroDenver description support presence, not measured share.

Health = (N clinical patients × judged eligible subgroup × delivered dose × incremental mode share × average annual trial-reference QALY − full patient process harm) × local share. Patient health is not reduced by household grouping. Household resources jointly log net gains and full access costs; distinct payer loss localized once. Price =10C/(health+signed income).

C
18893488 USD annual (observed). Observed FY2024 functional18,759,847 plus133,641directevent expense. [finance]
N
7901 annual observed unique patients (observed). Observed2024annual7,901unique patients, not visits or completed BHpatients. [annual]
unique
0.85 model parameter (judgment). Judged .85resource household grouping only; clinical patients remain7,901. [services] [cg-cost]
eligible
0.15 model parameter (judgment). Judged .15depression-compatible subgroup; service visits/dose provide plausibility not measured completion. [services] [cg-cost]
completion
0.7 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
b
0.3 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
response
1 model parameter (judgment). One because q already averages trial clinical response; no second responder efficacy factor. [services] [cg-cost]
q
0.02 model parameter (judgment). Conditional transferred CADET average 0.02 annual QALYs versus active usual care, CI−.02,.06; not recipient efficacy. [services] [cg-cost]
T
1 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
g
0.95 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
delay
0.1 model parameter (judgment). Judged .1-year service engagement start shared by clinical care and access/resource costs. [services] [cg-cost]
r
0.03 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
harm
0.0001 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
success
0.5 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
workGain
300 model parameter (judgment). Judged300net after-tax/benefit/work-cost adult or caregiver household resources, no child wages. [services] [cg-cost]
medicalGain
0 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
overlap
0.5 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
cost
5 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
baseline
20000 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
payerLoss
0 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
externalCost
0 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
payerPeople
10000 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]
payerBaseline
50000 model parameter (judgment). Explicit conditional judgment, not a measured causal recipient coefficient; adverse and null scenarios test this assumption. [services] [cg-cost]

central: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -0.42. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

trial lower interval: Cost: $18.9M; Denver health QALYs: -5.46; all-population health QALYs: -5.75. Income-equivalent healthy years: -0.42. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

trial upper interval: Cost: $18.9M; Denver health QALYs: 13.40; all-population health QALYs: 14.10. Income-equivalent healthy years: -0.42. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

narrower depression subgroup: Cost: $18.9M; Denver health QALYs: 2.39; all-population health QALYs: 2.52. Income-equivalent healthy years: -0.55. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

no transfer superiority: Cost: $18.9M; Denver health QALYs: -0.75; all-population health QALYs: -0.79. Income-equivalent healthy years: -0.80. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

active public alternative clinical and resource null: Cost: $18.9M; Denver health QALYs: -0.75; all-population health QALYs: -0.79. Income-equivalent healthy years: -0.80. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

clinical patient unit no household reduction: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -0.25. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

clinical null: Cost: $18.9M; Denver health QALYs: -0.75; all-population health QALYs: -0.79. Income-equivalent healthy years: -0.42. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

financial only: Cost: $18.9M; Denver health QALYs: 0.00; all-population health QALYs: 0.00. Income-equivalent healthy years: -0.42. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

zero benefit full burdens: Cost: $18.9M; Denver health QALYs: -0.75; all-population health QALYs: -0.79. Income-equivalent healthy years: -0.80. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

no exposure: Cost: $18.9M; Denver health QALYs: 0.00; all-population health QALYs: 0.00. Income-equivalent healthy years: 0.00. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

no gift no exposure: Cost: $0; Denver health QALYs: 0.00; all-population health QALYs: 0.00. Income-equivalent healthy years: 0.00. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

adverse: Cost: $18.9M; Denver health QALYs: -42.13; all-population health QALYs: -44.35. Income-equivalent healthy years: -2.06. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

unknown: Cost: unknown; Denver health QALYs: unknown; all-population health QALYs: unknown. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

no recipient resources: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -0.80. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

clinical response null: Cost: $18.9M; Denver health QALYs: -0.75; all-population health QALYs: -0.79. Income-equivalent healthy years: -0.80. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

short health: Cost: $18.9M; Denver health QALYs: 0.43; all-population health QALYs: 0.45. Income-equivalent healthy years: -0.42. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

one year health: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -0.42. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

low additionality: Cost: $18.9M; Denver health QALYs: 0.82; all-population health QALYs: 0.87. Income-equivalent healthy years: -0.67. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

all additionality: Cost: $18.9M; Denver health QALYs: 14.97; all-population health QALYs: 15.76. Income-equivalent healthy years: 0.45. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

half geography: Cost: $18.9M; Denver health QALYs: 1.04; all-population health QALYs: 4.18. Income-equivalent healthy years: -0.11. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

no local share: Cost: $18.9M; Denver health QALYs: 0.00; all-population health QALYs: 0.00. Income-equivalent healthy years: 0.00. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

no positive overlap: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -0.80. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

full positive overlap: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -0.05. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

negative overlap zero: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -1.12. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

negative overlap one: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -1.12. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

mixed resources: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -1.01. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

no access cost: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: 0.37. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

high access cost: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -7.59. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

higher payer incidence: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -0.52. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

higher volunteer opportunity: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -1.09. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

double cost: Cost: $37.8M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -0.42. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

functional only cost boundary: Cost: $18.8M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -0.42. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

half connections: Cost: $18.9M; Denver health QALYs: 1.98; all-population health QALYs: 2.09. Income-equivalent healthy years: -0.21. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

higher connections: Cost: $18.9M; Denver health QALYs: 5.95; all-population health QALYs: 6.26. Income-equivalent healthy years: -0.63. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

household deduplication: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -0.35. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

no net work gain: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -0.80. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

higher after cost work: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -0.17. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

no eligible subgroup: Cost: $18.9M; Denver health QALYs: -0.75; all-population health QALYs: -0.79. Income-equivalent healthy years: -0.80. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

no completed dose: Cost: $18.9M; Denver health QALYs: -0.75; all-population health QALYs: -0.79. Income-equivalent healthy years: -0.80. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

low clinical response: Cost: $18.9M; Denver health QALYs: 0.43; all-population health QALYs: 0.45. Income-equivalent healthy years: -0.70. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

no copay otherwise paid: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -0.42. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

three full year mean cost: Cost: $12.1M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -0.42. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

low completed dose: Cost: $18.9M; Denver health QALYs: -0.07; all-population health QALYs: -0.08. Income-equivalent healthy years: -0.74. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

no volunteer opportunity: Cost: $18.9M; Denver health QALYs: 3.97; all-population health QALYs: 4.18. Income-equivalent healthy years: -0.42. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

full completed dose: Cost: $18.9M; Denver health QALYs: 5.99; all-population health QALYs: 6.30. Income-equivalent healthy years: -0.26. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

Counterfactual: Other safety-net primary care and covered providers, usual depression treatment, sliding fees and HHS-funded services without Tepeyac integration.

Attribution: Judged .15depression-compatible subgroup,.7delivery-transfer and .3incremental enhanced-care share; .02trial-average utility is not recipient efficacy.

Eligibility, completion, active alternatives, clinical transfer, client residence, household grouping/resources and marginal gift capacity unmeasured. Other clinical channels unknown.

Sensitivity

  • trial lower interval: no finite positive estimate. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • trial upper interval: $1.5M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • narrower depression subgroup: $10.2M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • no transfer superiority: no finite positive estimate. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • active public alternative clinical and resource null: no finite positive estimate. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • clinical patient unit no household reduction: $5.1M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • clinical null: no finite positive estimate. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • financial only: no finite positive estimate. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • zero benefit full burdens: no finite positive estimate. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • no exposure: no finite positive estimate. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • no gift no exposure: no finite positive estimate. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • adverse: no finite positive estimate. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • unknown: no finite positive estimate. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • no recipient resources: $6.0M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • clinical response null: no finite positive estimate. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • short health: $2B per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • one year health: $5.3M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • low additionality: $123.7M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • all additionality: $1.2M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • half geography: $20.2M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • no local share: no finite positive estimate. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • no positive overlap: $6.0M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • full positive overlap: $4.8M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • negative overlap zero: $6.6M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • negative overlap one: $6.6M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • mixed resources: $6.4M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • no access cost: $4.4M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • high access cost: no finite positive estimate. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • higher payer incidence: $5.5M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • higher volunteer opportunity: $6.6M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • double cost: $10.7M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • functional only cost boundary: $5.3M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • half connections: $10.7M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • higher connections: $3.6M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • household deduplication: $5.2M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • no net work gain: $6.0M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • higher after cost work: $5.0M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • no eligible subgroup: no finite positive estimate. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • no completed dose: no finite positive estimate. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • low clinical response: no finite positive estimate. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • no copay otherwise paid: $5.3M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • three full year mean cost: $3.4M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • low completed dose: no finite positive estimate. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • no volunteer opportunity: $5.3M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.
  • full completed dose: $3.3M per DALY. Conditional FY2024 unique patient envelope with a judged depression-compatible subgroup, not summed statewide families or completed successes. The original CADET .02 average QALY is a conditional transfer reference, not all-recipient clinical efficacy; subgroup, delivery, household resources and alternative providers are judgments. Full annual costs include unknown other channels.

Unresolved inputs

  • Eligible depression clients and completed dose
  • Local controlled clinical outcomes and fidelity
  • Deduplicated household resources and residence
  • Other crisis/substance/pharmacy effects
  • Allocated channel costs and marginal donor capacity

Health and income breakdown

For the modeled $18.9M: 3.97 health QALYs + -0.42 income-equivalent healthy years in Denver: $5.3M per DALY. Income equivalents are welfare comparisons, not observed QALYs or DALYs.

Method and caveats.

5. Funding and previous grants

Own donation page embeds an actual Blackbaud donor form, with no transaction. Legal LaClinicaTepeyacInc DBA Tepeyac EIN84-1285505. Current payment page accepts Medicaid/Medicare/private insurance and family-income-based sliding fees. HHS support and other safety-net clinics are public-provider alternatives, not all donation-funded capacity. New clinic expansion and financial scale do not establish a next-gift effect.

Annual expenses

Organization-level spending, including programs, administration and fundraising. The research list averages three comparable, consecutive full fiscal years when available.

  • FY 2024: $18.9M; org:tepeyac, 12-month period, IRS full functional expenses plus netted direct event expenses. Source
  • FY 2023: $10.1M; org:tepeyac, 12-month period, IRS full functional expenses plus netted direct event expenses. Source
  • FY 2022: $7.3M; org:tepeyac, 12-month period, IRS full functional expenses plus netted direct event expenses. Source

6. Sources

  1. Current integrated bilingual behavioral-health services. Tepeyac Community Health Center. Published: not stated; retrieved: 2026-10-06.
  2. 2024annual unique patients and visits. Tepeyac Community Health Center. Published: not stated; retrieved: 2026-10-06.
  3. Original FY2024 full annual cost. IRS original filing. Published: not stated; retrieved: 2026-10-06.
  4. Original FY2023 full annual cost. IRS original filing. Published: not stated; retrieved: 2026-10-06.
  5. Original FY2022 full annual cost. IRS original filing. Published: not stated; retrieved: 2026-10-06.
  6. Current insurance and sliding-fee alternatives. Tepeyac Community Health Center. Published: not stated; retrieved: 2026-10-06.
  7. Own current Blackbaud donation intake. Tepeyac Community Health Center. Published: not stated; retrieved: 2026-10-06.
  8. Original CADET randomized utility comparison. NIHR Journals Library / original CADET investigators. Published: not stated; retrieved: 2026-10-06.
  9. Health and signed income comparison framework. Coefficient Giving. Published: not stated; retrieved: 2026-10-06.